The use of drugs for behavior modification as it relates to the practice of optometry--Part II.
Drugs used in behavior modification are considered with respect to type, specific agents, conditions for which they are used, and associated ocular and visual side effects. Relevant types include narcotic analgesics, sedatives and hypnotics, antipsychotics, antianxiety drugs, antidepressants, psychomotor stimulating agents, caffeine, the antihistamines, estrogen and progestins, vitamins, disulfiram, and illicit drugs and chemicals.
D000701:Analgesics, Opioid / Q000009:adverse effects; D014151:Anti-Anxiety Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D001521:Behavior Therapy / Q000379:methods*; D002110:Caffeine / Q000009:adverse effects; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D002648:Child; D004221:Disulfiram / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D004967:Estrogens / Q000009:adverse effects; D005123:Eye / Q000187:drug effects*; D005128:Eye Diseases / Q000139:chemically induced*; D006634:Histamine H1 Antagonists / Q000009:adverse effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D009907:Optometry; D011372:Progestins / Q000009:adverse effects; D019966:Substance-Related Disorders; D014815:Vitamins / Q000009:adverse effects
D000701:Analgesics, Opioid; D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants; D004967:Estrogens; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D011372:Progestins; D014815:Vitamins; D002110:Caffeine; D004221:Disulfiram